Amprius Technologies (AMPX) Back In Focus On Record Earnings And A Bigger Valuation Debate

Amprius Technologies

Amprius Technologies

AMPX

0.00

Why Amprius Technologies Stock Is Back In Focus After Guidance And Earnings

Amprius Technologies (AMPX) is in the spotlight after reporting record second quarter results and lifting its 2026 revenue outlook to at least US$140 million, alongside a narrower expected full year net loss.

The earnings beat and raised 2026 outlook have put Amprius Technologies back on traders’ radars. The share price at US$11.19 has seen mixed momentum, with a 7 day share price return of 18.16% alongside a 90 day share price return that declined 32.99%, while the 1 year total shareholder return of 44.95% points to a stronger longer term payoff profile.

If you are watching how battery and electrification trends are playing out beyond Amprius Technologies, this is a good time to scan 56 AI infrastructure stocks

Amprius Technologies now trades at a steep discount to both analyst targets and one fair value estimate, even after the post earnings jump. Is the market sensibly cautious about execution risk, or overly discounting the guidance upgrade?

Most Popular Narrative: 49.4% Undervalued

The most followed narrative on Amprius Technologies pegs fair value at $22.13 per share, compared with the latest close at $11.19, which frames much of the recent debate.

The analysts have a consensus price target of $22.12 for Amprius Technologies based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $18.0.

Curious what kind of revenue curve and margin shift would need to line up for that fair value to hold. The narrative leans on aggressive earnings expansion, richer profitability and a premium future multiple that many investors normally associate with mature high growth leaders.

Result: Fair Value of $22.13 (UNDERVALUED)

However, the Amprius Technologies story still hinges on concentrated aviation and drone demand and on scaling silicon anode production without cost or reliability setbacks.

Another View On Amprius Technologies Valuation

The narrative around Amprius Technologies leans heavily on a fair value of $22.13, supported by growth forecasts and analyst targets. Our DCF model, which prices the stock at $42.27 based on future cash flows, presents a more optimistic view of what the cash generation could justify.

That gap between the DCF output and today’s $11.19 share price raises a practical question for investors: is the market heavily discounting execution and funding risk, or are cash flow expectations simply too generous for a still unprofitable battery business?

AMPX Discounted Cash Flow as at Aug 2026
AMPX Discounted Cash Flow as at Aug 2026

Next Steps

With sentiment around Amprius Technologies split between optimism and caution, this is a moment to move quickly and rigorously stress test your own thesis using the 3 key rewards and 3 important warning signs.

Looking For More Investment Ideas Beyond Amprius Technologies?

If you are weighing what to do next after Amprius Technologies, do not stop with a single stock. Fresh ideas often come from comparing very different opportunities.

  • Spot potential upside in companies that the market may be overlooking by scanning the screener containing 19 high quality undiscovered gems, which is tailored around strong fundamentals and quieter coverage.
  • Strengthen your portfolio core by reviewing the solid balance sheet and fundamentals stocks screener (49 results) to focus on businesses with healthier financial footing and clearer funding flexibility.
  • Dial down portfolio swings by checking the 77 resilient stocks with low risk scores so you can concentrate your attention on companies with lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.